Latest News for: esmo

Edit

CytoDyn to Present Updated Data from Phase 2 CLOVER Clinical Study at ESMO Congress 2026

The Eagle-Tribune 08 Oct 2026
VANCOUVER, Washington, Oct ... (OTCQB.
Edit

Astellas Highlights Data Advancing Cancer Care and Innovation for Patients with Hard-to-Treat Cancers at ESMO 2026

Milton Independent 07 Oct 2026
– PADCEV™ (enfortumab vedotin) plus pembrolizumab data highlight durable survival benefit in advanced bladder cancer – ....
Edit

GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026

Independent Record 06 Oct 2026
GRAIL to Present Six Abstracts at the Early Detection of Cancer Conference (EDCC) Spanning Clinical Performance, Health Equity, and Real-World Implementation of Multi-Cancer Early Detection ... .
Edit

Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026

Nasdaq Globe Newswire 06 Oct 2026
Late-breaking Phase 3 C-POST data provide longer-term survival outcomes for adjuvant Libtayo� (cemiplimab) in high-risk cutaneous squamous cell carcinoma (CSCC) after surgery and radiation ... .
Edit

Agendia to Showcase New Research on AI-Driven Digital Pathology at ESMO 2026

Business Wire 06 Oct 2026
IRVINE, Calif. & AMSTERDAM--(BUSINESS WIRE)-- #BluePrint--Podium presentation by Agendia Co-Founder and Chief Research Officer Laura van ’t Veer introduces new AI-driven approach to MammaPrint ... .
Edit

Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026

Nasdaq Globe Newswire 05 Oct 2026
Rapid oral presentation of additional sub-group analyses from the VIKTORIA-1 PIK3CA mutant-type cohort ... .
Edit

Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO)

Hastings Tribune 05 Oct 2026
Rapid oral presentation of additional sub-group analyses from the VIKTORIA-1 PIK3CA mutant-type cohort ... .
Edit

GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026 (Grail Inc)

Public Technologies 05 Oct 2026
GRAIL to Present Two Abstracts at the European Society for Medical Oncology (ESMO) Congress, Across the Cancer Diagnostic Journey and Real-World Evidence ... ESMO Data Presentations.
Edit

Hummingbird Diagnostics to Present Blood-Based RNA Biomarker Data in Stage III Lung Cancer at ESMO 2026

Business Wire 30 Sep 2026
HEIDELBERG, Germany--(BUSINESS WIRE)--Hummingbird Diagnostics will present blood-based RNA biomarker data on prognosis and potential MRD assessment in stage III lung cancer at ESMO 2026 ... .
Edit

Oncoinvent to present three abstracts at EANM and ESMO 2026 (Oncoinvent ASA)

Public Technologies 30 Sep 2026
Two abstracts will be presented at EANM and one at ESMO ... "We are pleased to have three abstracts accepted for presentation at EANM and ESMO 2026 ... ESMO 2026.
Edit

HUYABIO International Announces Pivotal Data for HBI-8000 in Advanced Melanoma Selected for Late-Breaking Presentation at ESMO Congress 2026

PR Newswire 29 Sep 2026
The randomized global Phase 3 trial enrolled 404 patients across 15 countries.The abstract will be available on the ESMO website at 00.05 CET on Friday, October 23. Details of the ESMO Congress 2026 presentation.
Edit

CTTQ to Showcase New Oncology Data at ESMO 2026, Featuring TQB2102 and TQB2868 (Sino Biopharmaceutical Limited)

Public Technologies 29 Sep 2026
CTTQ, a core company of SBP Group (01177.HK), will present 21 clinical studies across its oncology portfolio at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain.
Edit

Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO

The Milton Standard Journal 28 Sep 2026
NEW YORK--(BUSINESS WIRE)--Sep 28, 2026-- ....
Edit

Immuneering to Present at the ESMO Congress 2026

Nasdaq Globe Newswire 25 Sep 2026
Immuneering to Present at the ESMO Congress 2026 ... .
Edit

HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2026 (Form 6-K) (HUTCHMED (China) Ltd)

Public Technologies 25 Sep 2026
HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2026 ... Society for Medical Oncology ("ESMO") Congress 2026, taking place on October 23-27, 2026, in Madrid, Spain.

Article Search

tools
×
×
×
×